Navigation Links
Exiqon Announces Positive Clinical Data From EORTC Clinical Trial Showing Oncotech EDR Assay Predicts Resistance to Platinum-Based Therapy in Ovarian Cancer
Date:10/27/2008

gnostic products will be based on the LNA(TM) technology that will enable testing on fixed tissue. The first molecular diagnostic product is scheduled for launch by the end of 2008. A number of new products will follow in the years ahead. Using the LNA(TM) technology is what has allowed Exiqon to establish a position for itself as one of the market's leading providers of research products for gene expression analysis. These research products are used by university scientists and in the pharmaceutical industry around the world to make groundbreaking discoveries about the correlation between gene activity and the development various diseases. Exiqon is also collaborating with pharmaceutical companies in their effort to develop new medicines based on biomarkers (Personalized Medicine). Exiqon has more than 200 employees and is listed on the NASDAQ OMX in Copenhagen and categorized as a biotech company (Small Cap+). Exiqon is financed until expected breakeven in 2011.

Disclaimer

Forward-looking statements: This announcement contains forward-looking statements regarding Exiqon's potential future development and financial performance and other statements, which are not historical facts. Such statements are made on the basis of assumptions and expectations which, to the best of Exiqon's knowledge, are reasonable and well-founded at this time, but which may prove to be erroneous. Exiqon's operations are characterized by the fact that its actual results may deviate significantly from that described herein as anticipated, believed, estimated or expected.


'/>"/>
SOURCE Exiqon A/S
Copyright©2008 PR Newswire.
All rights reserved

4

GOOD

Page: 1 2 3

Related biology technology :

1. Exiqon: Major Shareholder Announcement
2. Exiqon Appoints Cynthia French as Chief Scientific Officer and Erik Holmlin as Chief Commercial Officer
3. Exiqon Receives the 2008 Frost & Sullivan Growth Strategy Leadership Award
4. Exiqon A/S: Interim Report for the Period 1 January - 30 June 2008 (Unaudited)
5. Report Regarding the Managements and Closely Related Parties Transactions With Securities in Exiqon A/S
6. Exiqon A/S Today Announces a Grant of License to Roche Diagnostics
7. Exiqon A/S Announces U.S. Subsidiary Name Change From Oncotech, Inc. to Exiqon Diagnostics, Inc.
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
10. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
11. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... 2 Nearly 600 medical r... funders today convened to explore novel developme... the inaugural Partnering for Cures meeting. ,...the Milken Institute, convened Partnering for Cur...ed to turn a scientific discovery into an accessib...
(Date:12/2/2009)..., Gabon, December 2 , - "...lem and Heritage" , Coinciding with the I...he,Gabonese Republic is hosting an international c...feguarding biological resources in Africa. The,con...eaders, ministers,scientific experts, private com...
(Date:12/2/2009)..., Dec. 2 S*BIO Pte Ltd today annou...ibitor, SB1518, at The American Society of Hematol...ans. ,, Data will be presented on the clinical ...SB1518 detailing its safety, tolerability and phar...e levels ranging from 100 to 600 mg. These doses w...
(Date:12/2/2009)..., Dec. 2 /PRNewswire-Asia/ -- The world is going t... and uncertainty is part of many,businesses and in...s been,relatively immune to the economic downturn,... During the midst of the difficult times this ye... inaugurated an R&D center in Shanghai, the la...
Breaking Biology Technology:Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Libreville International Conference 2-3 June 2010 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3
...e quantities of difficult-to-express proteins ,...iochemical & Molecular Allergology, Research Cente...odonPlus(DE3)-RIL cells * with,extra copies of E...ossible to attain high-level expression of difficu...nduced expression of several recombinant peanut al...
...RoboCycler Gradient 96 temperature cycler ,,.... , Stratagenes RoboCycler Gradient 96 tempera...ed to perform fluorescent-tag cycle,sequencing u...ing,ready reaction kit. The new Hot Top Assembly...ays that hinder the loading of cycle sequencing re...
...,, Achieve superior transfection efficiencie...cott Basehore Jeff Braman ,Stratagene , Plasm...,EF plasmid midiprep kit, a kit based on anion e...um chloride density gradient centrifugation. Plasm...-nm optical density ratios) were comparable,with...
Other Biology Technology:High-Level Expression of Peanut Allergens Affected by Rare Codon Usage 2High-Level Expression of Peanut Allergens Affected by Rare Codon Usage 3High-Level Expression of Peanut Allergens Affected by Rare Codon Usage 4Automated Fluorescent-Tag Cycle Sequencing 2Automated Fluorescent-Tag Cycle Sequencing 3Automated Fluorescent-Tag Cycle Sequencing 4Automated Fluorescent-Tag Cycle Sequencing 5Highest Transfection Efficiency of an Endotoxin-Sensitive Mammalian Cell,Line 2Highest Transfection Efficiency of an Endotoxin-Sensitive Mammalian Cell,Line 3Highest Transfection Efficiency of an Endotoxin-Sensitive Mammalian Cell,Line 4
(Date:12/3/2009)...design of the upcoming forest deal at Copenhagen i...to a scientist at the University of Leeds. , Wr...t at least 50% of the carbon credit payments to be...ssions from Deforestation and Degredation), should...operty rights assured. , "There is the potential...
(Date:12/3/2009)... U.S. Department of Energy,s (DOE) Brookhaven Nati...n Institute of Science has made a major step in un...mation in DNA that is necessary to carry out impor... in the December 1, 2009 edition of Nature Struct...eins responsible for interacting at specific sites...
(Date:12/2/2009)...no men have a more difficult time quitting smoking...ure, but acculturation has no affect on Latinas od...are published in Cancer Epidemiology, Biomarkers ...on for Cancer Research. The December issue has a s...s smoking cessation differently for Latino men and...
Breaking Biology News(10 mins):Forest deal at Copenhagen must avoid creating 'carbon refugees' 2Grooving down the helix 2Grooving down the helix 3Acculturation affects smoking cessation success among Latinos 2A Pets Bite Can Pass on MRSA 49599 1A Pets Bite Can Pass on MRSA 49599 2Spinal Cancer Patient Finds New Hope at the Palo Alto Medical Foundation 49594 1Spinal Cancer Patient Finds New Hope at the Palo Alto Medical Foundation 49594 2Spinal Cancer Patient Finds New Hope at the Palo Alto Medical Foundation 49594 3Spinal Cancer Patient Finds New Hope at the Palo Alto Medical Foundation 49594 4HealthLeaders InterStudy Unveils Enhanced Employer Vantage 49589 1HealthLeaders InterStudy Unveils Enhanced Employer Vantage 49589 2
... desperately try to reach for a break in the canop... affliction: Shade avoidance syndrome or SAS. Now,... light by researchers at the Salk Institute for Bi...rs shade, plants switch on a natural chemical fact...auxin that lets a plant grow and ultimately stretc...
...the inaugural conference of the iPlant Collaborati... virtual center in cyberspace for plant sciences r...itled "Bringing Plant and Computing Scientists Tog...nd scheduled for April 7-9, 2008, will take the fi...test unsolved mysteries its grand challenge quest...
... Society of Agronomy (ASA), Crop Science Society o...ica (SSSA) recognize the following undergraduate s... National Student Recognition Program announced in...ine. , The 2008 National Student Recognition Prog...s enrolled in agronomy, crop, soil, or environment...
Other Biology News:A place in the sun 2A place in the sun 3iPlant Kickoff Conference at CSHL begins tackling plant biology's grand challenges 2iPlant Kickoff Conference at CSHL begins tackling plant biology's grand challenges 3Outstanding undergraduates recognized in agronomy, crop, soil, and environmental sciences 2
...noCortin (POMC) has long been a molecule of fascin... of biologically-active peptides such as ACTH, -Li...mulating Hormone (a-MSH) and more. It is also a ve...rtebrates studied, including those "living fossils...
Mouse Anti-Rat Pan-NMDA NR1 Monoclonal Antibody, Unconjugated, Clone R1JHL from Calbiochem
BRASMC (B950-05) from European Collection of Cell Cultures (ECACC)
T4 DNA Ligase from Promega
Biology Products: